Methods and systems for analyzing nucleic acid molecules
AssigneeGuardant Health, Inc.
InventorAndrew KENNEDY
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods for processing nucleic acid populations containing different forms (e.g., RNA and DNA, single-stranded or double-stranded) and/or extents of modification (e.g., cytosine methylation, association with proteins). These methods accommodate multiple forms and/or modifications of nucleic acid in a sample, such that sequence information can be obtained for multiple forms. The methods also preserve the identity of multiple forms or modified states through processing and analysis, such that analysis of sequence can be combined with epigenetic analysis.
Claims22
A method of determining presence or absence of a cancer in a subject, the method comprising:
- (a) obtaining a cell-free DNA sample from the subject, wherein the cell-free DNA sample comprises methylated cell-free DNA and unmethylated cell-free DNA;
- (b) contacting the sample with one or more agents that discriminates between the methylated cell-free DNA and unmethylated cell-free DNA to provide contacted methylated cell-free DNA and contacted methylated cell-free DNA;
- (c) enriching the contacted methylated cell-free DNA, or amplicons thereof, and contacted unmethylated cell-free DNA, or amplicons thereof, for target regions using target-specific probes to provide captured DNA, wherein the target regions comprise cancer-associated differentially methylated regions (DMRs), and wherein the DMRs exhibit differential methylation between DNA obtained from healthy subjects and DNA obtained from subjects having the cancer;
- (d) sequencing the captured DNA, or amplicons thereof, to provide sequence information;
- and
- (e) determining the presence or absence of the cancer in the subject by inputting features derived from the set of sequence reads into a trained classifier, wherein the trained classifier is trained using data obtained from subjects who have the cancer, subjects who do not have cancer, and/or subjects who have other types of cancer.
Dependencies are inferred from the claim text.